Effect of DNA methylation status on first-line anti-epidermal growth factor receptor treatment in patients with metastatic colorectal cancer

被引:0
|
作者
Hiroki Osumi
Kota Ouchi
Eiji Shinozaki
Shin Takahashi
Akira Ooki
Izuma Nakayama
Takeru Wakatsuki
Mariko Ogura
Daisuke Takahari
Keisho Chin
Kensei Yamaguchi
Chikashi Ishioka
机构
[1] Cancer Institute Hospital,Department of Gastroenterology
[2] Japanese Foundation for Cancer Research,Department of Medical Oncology
[3] Tohoku University Hospital,Department of Clinical Oncology
[4] Tohoku University Graduate School of Medicine,undefined
关键词
DNA methylation; Epidermal growth factor receptor inhibitor; Metastatic colorectal cancer; Predictive biomarker;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1439 / 1447
页数:8
相关论文
共 50 条
  • [1] Effect of DNA methylation status on first-line anti-epidermal growth factor receptor treatment in patients with metastatic colorectal cancer
    Osumi, Hiroki
    Ouchi, Kota
    Shinozaki, Eiji
    Takahashi, Shin
    Ooki, Akira
    Nakayama, Izuma
    Wakatsuki, Takeru
    Ogura, Mariko
    Takahari, Daisuke
    Chin, Keisho
    Yamaguchi, Kensei
    Ishioka, Chikashi
    [J]. INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2022, 37 (06) : 1439 - 1447
  • [2] DNA methylation status as a biomarker of anti-epidermal growth factor receptor treatment for metastatic colorectal cancer
    Ouchi, Kota
    Takahashi, Shin
    Yamada, Yasuhide
    Tsuji, Shingo
    Tatsuno, Kenji
    Takahashi, Hidekazu
    Takahashi, Naoki
    Takahashi, Masanobu
    Shimodaira, Hideki
    Aburatani, Hiroyuki
    Ishioka, Chikashi
    [J]. CANCER SCIENCE, 2015, 106 (12) : 1722 - 1729
  • [3] First-line use of anti-epidermal growth factor receptor monoclonal antibodies in metastatic colorectal cancer
    Lee, James J.
    Chu, Edward
    [J]. CLINICAL COLORECTAL CANCER, 2007, 6 : S42 - S46
  • [4] Clinical impact of anti-epidermal growth factor receptor monoclonal antibodies in first-line treatment of metastatic colorectal cancer
    Loupakis, Fotios
    Cremolini, Chiara
    Salvatore, Lisa
    Schirripa, Marta
    Lonardi, Sara
    Vaccaro, Vanja
    Cuppone, Federica
    Giannarelli, Diana
    Zagonel, Vittorina
    Cognetti, Francesco
    Tortora, Giampaolo
    Falcone, Alfredo
    Bria, Emilio
    [J]. CANCER, 2012, 118 (06) : 1523 - 1532
  • [5] Clinical impact of DNA methylation status on first-line antiepidermal growth factor receptor treatment in patients with metastatic colorectal cancer.
    Osumi, Hiroki
    Ouchi, Kota
    Shinozaki, Eiji
    Takahashi, Shin
    Ooki, Akira
    Shimozaki, Keitaro
    Nakayama, Izuma
    Wakatsuki, Takeru
    Ogura, Mariko
    Takahari, Daisuke
    Chin, Keisho
    Yamaguchi, Kensei
    Ishioka, Chikashi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [6] Anti-Epidermal Growth Factor Receptor Antibodies in the Treatment of Metastatic Colorectal Cancer
    Kendall, Anne
    Lord, Rosemary
    Maisey, Nick
    [J]. RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2010, 5 (02) : 142 - 151
  • [7] Efficacy of Second-Line Bevacizumab-Containing Chemotherapy for Patients with Metastatic Colorectal Cancer following First-Line Treatment with an Anti-Epidermal Growth Factor Receptor Antibody
    Hasegawa, Hiroko
    Taniguchi, Hiroya
    Mitani, Seiichiro
    Masuishi, Toshiki
    Komori, Azusa
    Narita, Yukiya
    Kadowaki, Shigenori
    Ura, Takashi
    Ando, Masashi
    Yatabe, Yasushi
    Muro, Kei
    [J]. ONCOLOGY, 2017, 92 (04) : 205 - 212
  • [8] Anti-epidermal or anti-vascular endothelial growth factor as first-line metastatic colorectal cancer in modified Glasgow prognostic score 2′ patients
    Dreanic, Johann
    Dhooge, Marion
    Barret, Maximilien
    Brezault, Catherine
    Mir, Olivier
    Chaussade, Stanislas
    Coriat, Romain
    [J]. JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2015, 6 (03) : 231 - 236
  • [9] Bevacizumab versus anti-epidermal growth factor receptor in first-line metastatic colorectal cancer. A meta-analysis: The last building block?
    Ducreux, Michel
    Pignon, Jean-Pierre
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 69 : 178 - 179
  • [10] The Developing Role of Anti-Epidermal Growth Factor Receptor Agents in the Treatment of Advanced or Metastatic Colorectal Cancer
    Ursem, Carling
    Venook, Alan P.
    [J]. ONCOLOGY-NEW YORK, 2017, 31 (11): : 785 - +